Heberprot-P (recombinant epidermal growth factor)
Heberprot-P (factor de crecimiento epidérmico recombinante)
- Date
- c. 2006 · confidence medium
- Place
- Centre for Genetic Engineering and Biotechnology, Havana, Cuba
- Credited to
- Cuba's Centre for Genetic Engineering and Biotechnology
- Field
- Life & health
What it is
Injection into the diabetic foot ulcer of recombinant human epidermal growth factor to stimulate healing and reduce amputations. It was registered in Cuba and exported to other countries.
The registration date (2006) and comparative efficacy rest mainly on trials published by the centre itself; independent evidence is limited.
What it led to
- Reduction of diabetic foot amputations
- Cuban biotechnology exports
- Local growth-factor therapies